OBJECTIVE: Genome-wide association studies have successfully elucidated the genetic background of complex diseases, but X chromosomal data have usually not been analyzed. A reason for this is that there is no consensus approach for the analysis taking into account the specific features of X chromosomal data. This contribution evaluates test statistics proposed for X chromosomal markers regarding type I error frequencies and power. METHODS: We performed extensive simulation studies covering a wide range of different settings. Besides characteristics of the general population, we investigated sex-balanced or unbalanced sampling procedures as well as sex-specific effect sizes, allele frequencies and prevalence. Finally, we applied the test statistics to an association data set on Crohn's disease. RESULTS: Simulation results imply that in addition to standard quality control, sex-specific allele frequencies should be checked to control for type I errors. Furthermore, we observed distinct differences in power between test statistics which are determined by sampling design and sex specificity of effect sizes. Analysis of the Crohn's disease data detects two previously unknown genetic regions on the X chromosome. CONCLUSION: Although no test is uniformly most powerful under all settings, recommendations are offered as to which test performs best under certain conditions.
OBJECTIVE: Genome-wide association studies have successfully elucidated the genetic background of complex diseases, but X chromosomal data have usually not been analyzed. A reason for this is that there is no consensus approach for the analysis taking into account the specific features of X chromosomal data. This contribution evaluates test statistics proposed for X chromosomal markers regarding type I error frequencies and power. METHODS: We performed extensive simulation studies covering a wide range of different settings. Besides characteristics of the general population, we investigated sex-balanced or unbalanced sampling procedures as well as sex-specific effect sizes, allele frequencies and prevalence. Finally, we applied the test statistics to an association data set on Crohn's disease. RESULTS: Simulation results imply that in addition to standard quality control, sex-specific allele frequencies should be checked to control for type I errors. Furthermore, we observed distinct differences in power between test statistics which are determined by sampling design and sex specificity of effect sizes. Analysis of the Crohn's disease data detects two previously unknown genetic regions on the X chromosome. CONCLUSION: Although no test is uniformly most powerful under all settings, recommendations are offered as to which test performs best under certain conditions.
Authors: Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho Journal: Science Date: 2006-10-26 Impact factor: 47.728
Authors: John D Rioux; Ramnik J Xavier; Kent D Taylor; Mark S Silverberg; Philippe Goyette; Alan Huett; Todd Green; Petric Kuballa; M Michael Barmada; Lisa Wu Datta; Yin Yao Shugart; Anne M Griffiths; Stephan R Targan; Andrew F Ippoliti; Edmond-Jean Bernard; Ling Mei; Dan L Nicolae; Miguel Regueiro; L Philip Schumm; A Hillary Steinhart; Jerome I Rotter; Richard H Duerr; Judy H Cho; Mark J Daly; Steven R Brant Journal: Nat Genet Date: 2007-04-15 Impact factor: 38.330
Authors: Nilesh J Samani; Jeanette Erdmann; Alistair S Hall; Christian Hengstenberg; Massimo Mangino; Bjoern Mayer; Richard J Dixon; Thomas Meitinger; Peter Braund; H-Erich Wichmann; Jennifer H Barrett; Inke R König; Suzanne E Stevens; Silke Szymczak; David-Alexandre Tregouet; Mark M Iles; Friedrich Pahlke; Helen Pollard; Wolfgang Lieb; Francois Cambien; Marcus Fischer; Willem Ouwehand; Stefan Blankenberg; Anthony J Balmforth; Andrea Baessler; Stephen G Ball; Tim M Strom; Ingrid Braenne; Christian Gieger; Panos Deloukas; Martin D Tobin; Andreas Ziegler; John R Thompson; Heribert Schunkert Journal: N Engl J Med Date: 2007-07-18 Impact factor: 91.245
Authors: Augusto Anguita-Ruiz; Julio Plaza-Diaz; Francisco Javier Ruiz-Ojeda; Azahara I Rupérez; Rosaura Leis; Gloria Bueno; Mercedes Gil-Campos; Rocío Vázquez-Cobela; Ramón Cañete; Luis A Moreno; Ángel Gil; Concepción María Aguilera Journal: Sci Data Date: 2019-07-22 Impact factor: 6.444
Authors: Cristina M Justice; Araceli Cuellar; Krithi Bala; Jeremy A Sabourin; Michael L Cunningham; Karen Crawford; Julie M Phipps; Yan Zhou; Deirdre Cilliers; Jo C Byren; David Johnson; Steven A Wall; Jenny E V Morton; Peter Noons; Elizabeth Sweeney; Astrid Weber; Katie E M Rees; Louise C Wilson; Emil Simeonov; Radka Kaneva; Nadezhda Yaneva; Kiril Georgiev; Assen Bussarsky; Craig Senders; Marike Zwienenberg; James Boggan; Tony Roscioli; Gianpiero Tamburrini; Marta Barba; Kristin Conway; Val C Sheffield; Lawrence Brody; James L Mills; Denise Kay; Robert J Sicko; Peter H Langlois; Rachel K Tittle; Lorenzo D Botto; Mary M Jenkins; Janine M LaSalle; Wanda Lattanzi; Andrew O M Wilkie; Alexander F Wilson; Paul A Romitti; Simeon A Boyadjiev Journal: Hum Genet Date: 2020-04-07 Impact factor: 4.132